TY - JOUR
T1 - New approach for assessing vascular distribution within bone tumors using dynamic contrast-enhanced MRI
AU - Kawakami, Yukio
AU - Kunisada, Toshiyuki
AU - Sugihara, Shinsuke
AU - Ono, Atsushi
AU - Nishida, Keiichiro
AU - Abe, Nobuhiro
AU - Kawai, Akira
AU - Fujiwara, Kazuo
AU - Morimoto, Yuki
AU - Ozaki, Toshifumi
N1 - Funding Information:
Acknowledgments This work was supported in part by a Grant-in-aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (No.18791040, No.15790792), by a grant from Japan Orthopaedics and Traumatology Foundation Inc. (No.0158), by Grants-in-Aid for Clinical Cancer Research and Grants-in-Aid for Cancer Research (14S-4 and -5) from the Ministry of Health, Labor and Welfare, and by a grant from JSPS Fujita Memorial Fund for Medical Research.
PY - 2007/10
Y1 - 2007/10
N2 - Purpose: To differentiate benign from malignant bone tumors by analyzing the vascular distribution within bone tumors with dynamic contrast-enhanced MRI. Methods: We studied dynamic contrast-enhanced MRI for 49 bone tumors (22 malignant and 27 benign tumors). Seven small regions of interest (ROI) were set inside the largest portion of each tumor. Four ROI were placed evenly on the periphery and three ROI were placed evenly on the line of the longest breadth within the tumor. The slope of the curve (%Slope) was calculated on the time-intensity curves of the whole tumor and of each ROI. The variance values for the %Slope of the ROI were calculated to assess the dispersion of the intensity change at each ROI within the tumor. Results: Mean value of the %Slopes of whole tumor regions for malignant bone tumors (70.4 ± 60.3%) was significantly higher than that for benign bone tumors (37.6 ± 52.9%) (P = 0.015), although giant cell tumor (GCT), a locally aggressive tumor, had a relatively higher %Slope. Mean value of the variance of %Slopes for malignant bone tumors (3485.9 ± 5942.5) was significantly higher than that for all benign tumors (470.4 ± 583.9) (P = 0.012), indicating that the %Slope values of seven ROI within malignant bone tumors varied more widely compared with the ROI inside benign bone tumors. GCT also demonstrated a lower value. Conclusion: Our method of analyzing the signal intensity change at seven separate regions that evaluates the vascular distribution within a tumor could be a useful tool for differentiating between benign and malignant bone tumors.
AB - Purpose: To differentiate benign from malignant bone tumors by analyzing the vascular distribution within bone tumors with dynamic contrast-enhanced MRI. Methods: We studied dynamic contrast-enhanced MRI for 49 bone tumors (22 malignant and 27 benign tumors). Seven small regions of interest (ROI) were set inside the largest portion of each tumor. Four ROI were placed evenly on the periphery and three ROI were placed evenly on the line of the longest breadth within the tumor. The slope of the curve (%Slope) was calculated on the time-intensity curves of the whole tumor and of each ROI. The variance values for the %Slope of the ROI were calculated to assess the dispersion of the intensity change at each ROI within the tumor. Results: Mean value of the %Slopes of whole tumor regions for malignant bone tumors (70.4 ± 60.3%) was significantly higher than that for benign bone tumors (37.6 ± 52.9%) (P = 0.015), although giant cell tumor (GCT), a locally aggressive tumor, had a relatively higher %Slope. Mean value of the variance of %Slopes for malignant bone tumors (3485.9 ± 5942.5) was significantly higher than that for all benign tumors (470.4 ± 583.9) (P = 0.012), indicating that the %Slope values of seven ROI within malignant bone tumors varied more widely compared with the ROI inside benign bone tumors. GCT also demonstrated a lower value. Conclusion: Our method of analyzing the signal intensity change at seven separate regions that evaluates the vascular distribution within a tumor could be a useful tool for differentiating between benign and malignant bone tumors.
KW - Bone tumors
KW - Differential diagnosis
KW - Dynamic contrast-enhanced MRI
UR - http://www.scopus.com/inward/record.url?scp=34548288093&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34548288093&partnerID=8YFLogxK
U2 - 10.1007/s00432-006-0190-9
DO - 10.1007/s00432-006-0190-9
M3 - Article
C2 - 17534662
AN - SCOPUS:34548288093
SN - 0171-5216
VL - 133
SP - 697
EP - 703
JO - Journal of Cancer Research and Clinical Oncology
JF - Journal of Cancer Research and Clinical Oncology
IS - 10
ER -